Back to Search
Start Over
Synthesis and Evaluation of 3-(furo[2,3 -b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3 β Inhibitors and Anti-Ischemic Agents.
- Source :
-
Chemical Biology & Drug Design . Oct2015, Vol. 86 Issue 4, p746-752. 7p. - Publication Year :
- 2015
-
Abstract
- A series of novel 3-(furo[2,3 -b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides were designed, synthesized, and biologically evaluated for their GSK-3 β inhibitory activities. Most compounds showed favorable inhibitory activities against GSK-3 β protein. Among them, compounds 5n, 5o, and 5p significantly reduced GSK-3 β substrate tau phosphorylation at Ser396 in primary neurons, indicating inhibition of cellular GSK-3 β activity. In the in vitro neuronal injury models, compounds 5n, 5o, and 5p prevented neuronal death against glutamate, oxygen-glucose deprivation, and nutrient serum deprivation which are closely associated with cerebral ischemic stroke. In the in vivo cerebral ischemia animal model, compound 5o reduced infarct size by 10% and improved the neurological deficit. The results may provide new insights into the development of novel GSK-3 β inhibitors with potential neuroprotective activity against brain ischemic stroke. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 17470277
- Volume :
- 86
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Chemical Biology & Drug Design
- Publication Type :
- Academic Journal
- Accession number :
- 109976376
- Full Text :
- https://doi.org/10.1111/cbdd.12546